<DOC>
	<DOC>NCT00990665</DOC>
	<brief_summary>The objective of this study is to assess the safety and efficacy of the Quartet™ lead and Promote Q® device system in a patient population indicated for cardiac resynchronization therapy.</brief_summary>
	<brief_title>Promote Q Cardiac Resynchronization Therapy Defibrillator (CRT-D) and Quartet Left Ventricular Heart Lead Study</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ethinyl estradiol, levonorgestrel drug combination</mesh_term>
	<criteria>Approved indication per ACC/AHA/HRS guidelines for implantation of a CRTD system for treatment of heart failure or lifethreatening ventricular tachyarrhythmia(s) Receiving a new implant or undergoing an upgrade from an existing ICD or pacemaker implant with no prior LV lead placement. Ability to provide informed consent for study participation and is willing and able to comply with the prescribed followup tests and schedule of evaluations Have had a recent CVA or TIA within three months of enrollment Have a contraindication for an emergency thoracotomy Have a hypersensitivity to a single 1.0mg dose of dexamethasone sodium phosphate or short term contact with heparin Have a classification of Status 1 for cardiac transplantation or consideration for transplantation over the next 3 months Have undergone a cardiac transplantation within 40 days of enrollment Have had a recent myocardial infarction, unstable angina or cardiac revascularization (PTCA, Stent or CABG) within 40 days of enrollment Are currently participating in a clinical investigation that includes an active treatment arm Are pregnant or planning to become pregnant during the duration of the study Have a life expectancy of less than 6 months due to any condition Are less than 18 years of age Are unable to comply with the follow up schedule</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>CRT</keyword>
	<keyword>Heart Failure</keyword>
	<keyword>LV Leads</keyword>
</DOC>